Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of ILK polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Rabbit |
| Applications | WB-Ce,IHC-P |
More info about ILK polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB3057 |
| Product name: | ILK polyclonal antibody |
| Product description: | Rabbit polyclonal antibody raised against synthetic peptide of ILK. |
| Gene id: | 3611 |
| Gene name: | ILK |
| Gene alias: | DKFZp686F1765|P59 |
| Gene description: | integrin-linked kinase |
| Immunogen: | A synthetic peptide (conjugated with KLH) corresponding to N-terminus of human ILK1. |
| Protein accession: | O55222 |
| Form: | Liquid |
| Recommend dilutions: | Western Blot (1:1000) Immunohistochemistry (1:50-100) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In PBS (0.09% sodium azide) |
| Storage instruction: | Store at 4°C. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Rabbit |
| Antigen species / target species: | Human |
| Reactivity: | Human |
| Application image: |  |
| Application image note: | Western blot analysis of Ilk polyclonal antibody (Cat # PAB3057) in HL-60 cell lysate. ILK (Arrow) was detected using purified polyclonal antibody. Secondary HRP-anti-rabbit was used for signal visualization with chemiluminescence. |
| Applications: | WB-Ce,IHC-P |
| Shipping condition: | Dry Ice |
| Publications: | Carcinoembryonic antigen inhibits anoikis in colorectal carcinoma cells by interfering with TRAIL-R2 (DR5) signaling.Samara RN, Laguinge LM, Jessup JM. Cancer Res. 2007 May 15;67(10):4774-82. |